Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications.
about
Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogsEvolutionary modeling of rate shifts reveals specificity determinants in HIV-1 subtypesProbing sequence variation in the receptor-targeting domain of feline leukemia virus envelope proteins with peptide display libraries.Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine.Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization.Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein.Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated regionInactivation of human immunodeficiency virus type 1 by porphyrins.A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C.Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization.Impact of CCR5delta32 host genetic background and disease progression on HIV-1 intrahost evolutionary processes: efficient hypothesis testing through hierarchical phylogenetic modelsSubtype-specific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteins.Mutational Analysis of Lassa Virus Glycoprotein Highlights Regions Required for Alpha-Dystroglycan Utilization.Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein.Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies.Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis.Effect of Amino Acid Substitutions Within the V3 Region of HIV-1 CRF01_AE on Interaction with CCR5-Coreceptor.Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor.NMR observation of HIV-1 gp120 conformational flexibility resulting from V3 truncation.
P2860
Q28344169-5C25D6A0-65D4-4903-B84C-7BAC67B41990Q28473878-AEA36CC8-564D-45D4-A674-2F0132AAD693Q33210857-DE56F701-36DF-470A-906F-1D003A1BB7EBQ33576984-568A5F4F-8848-4831-A47B-128E64F2FB56Q33819515-B1CD87DA-5A01-44D0-A353-574BE5AB0E6EQ33841935-D4B6D7A2-6177-42F9-8216-313BF6E64A3CQ33851405-0C780F6B-4BDD-4281-836C-A5F9A9DFA22AQ33851913-F73BF25E-BF6A-484B-81D1-652E69F481C6Q33870292-39B36DBB-620A-456D-833A-8818F3F79D23Q34253386-5B1485BC-3AE9-48CC-B31C-4A32606251F0Q34478387-D52E066B-9DF6-4D61-A3F4-93D6089B71F2Q34744722-2BB1FF85-5A02-4CE4-9C30-9D9631274CF4Q34823713-BE88D0CA-5CEC-4F02-86B0-B59D52ADF3B0Q36424523-3BCEEA49-EAE1-43F4-BDA1-3733FC3C8F6CQ38662402-EF48330E-4782-48E2-86DA-FFA9A052878DQ38911714-80AF7BE5-D76A-470C-A874-0353703216ADQ39466299-BAAF64E5-3EC9-4563-B153-BC594EB1FC38Q40147993-A0748ADE-51D0-4091-9CC9-D24B2CF475D1Q40204210-95E8993A-3B00-4B1C-993B-04E5ACF95B57Q40209126-34B37ABA-912A-436E-8521-1349E422459DQ42219237-1D2F649D-99EA-4090-BEBD-EBFC054C71DD
P2860
Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Hypervariable region 3 residue ...... and prophylactic implications.
@ast
Hypervariable region 3 residue ...... and prophylactic implications.
@en
type
label
Hypervariable region 3 residue ...... and prophylactic implications.
@ast
Hypervariable region 3 residue ...... and prophylactic implications.
@en
prefLabel
Hypervariable region 3 residue ...... and prophylactic implications.
@ast
Hypervariable region 3 residue ...... and prophylactic implications.
@en
P2093
P2860
P356
P1476
Hypervariable region 3 residue ...... and prophylactic implications.
@en
P2093
P2860
P304
P356
10.1073/PNAS.96.8.4558
P407
P577
1999-04-01T00:00:00Z